Study of NAC of GA Therapy for Patients With BRPC
NCT02926183
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Ductal Adenocarcinoma
Interventions
DRUG:
Neoadjuvant chemotherapy of gemcitabine plus nab-paclitaxel
Sponsor
Wakayama Medical University